Results 361 to 370 of about 149,400 (379)
Some of the next articles are maybe not open access.
Autocrine mechanisms of cancer chemoresistance
Seminars in Cell & Developmental Biology, 2018An ever-increasing number of studies highlight the role of cancer secretome in the modification of tumour microenvironment and in the acquisition of cancer cell resistance to therapeutic drugs. The knowledge of the mechanisms underlying the relationship between cancer cell-secreted factors and chemoresistance is becoming fundamental for the ...
BUTERA, GIOVANNA +2 more
openaire +4 more sources
A short update on cancer chemoresistance [PDF]
Wiener Medizinische Wochenschrift, 2014 Chemotherapeutic interventions in cancer patients are limited by the appearance of chemoresistance. For instance, advanced lung and ovarian cancer patients relapse invariably after few cycles of platinum-based chemotherapy. Disseminated tumors are characterized by genetic instability/heterogeneity, thus containing or generating a repertoire of ...
Gerhard Hamilton, Barbara Rath
openaire +2 more sources
Modulation of Apoptosis to Reverse Chemoresistance
2008Interference with the innate apoptotic activity is a hallmark of neoplastic transformation and tumor formation. Modulation of the apoptotic cascade has been proposed as a new approach for the treatment of cancer. In this chapter, we discuss the role of apoptosis in ovarian cancer and the use of phenoxodiol as a model for the regulation of apoptosis and
Gil Mor +2 more
openaire +3 more sources
A snapshot of chemoresistance to PARP inhibitors
Trends in Pharmacological Sciences, 2012The exploitation of synthetic lethality in BRCA-deficient tumor carriers using potent inhibitors of the enzyme poly(ADP-ribose) polymerase (PARP)-1 has led to an enthusiastic response among basic scientists, oncologists and pharmaceutical companies. However, accumulating evidence demonstrates that resistance to these drugs develops in tumors in both ...
openaire +4 more sources
Chemoresistance in rat ovarian tumours
European Journal of Cancer and Clinical Oncology, 1991In a cisplatin resistant subline (O-342/DPP) of an intraperitoneally growing transplantable rat ovarian tumour (O-342), intracellular glutathione (GSH) was approximately doubled (mean [S.E.] 1.5 [0.26] vs. 0.8 [0.2] nmol/10(6) cells). GSH reductase activity was higher (30.64 [4.07] vs.
Eva Frei +5 more
openaire +3 more sources
Cancer chemoresistance and its mechanisms: Associated molecular factors and its regulatory role
Medical Oncology, 2023Sandra Kannampuzha, A. Gopalakrishnan
semanticscholar +1 more source
Natural Polyphenols in Cancer Chemoresistance
Nutrition and Cancer, 2016Resistance to chemotherapy remains a major impediment to the management of most types of cancer. Both intrinsic and acquired drug resistance are mediated by several cellular and molecular mechanisms, including alternative growth-signaling pathways unaffected by specific therapies, alterations in the tumor microenvironment (e.g., hypoxia and ...
Amal Ajaweed Sulaiman +5 more
openaire +3 more sources
Leishmaniasis: efflux pumps and chemoresistance
International Journal of Antimicrobial Agents, 2003Resistance of parasitic protozoa such as Leishmania to therapeutic drugs continues to escalate in developing countries. Treatment programs for human leishmaniasis are still based on pentavalent antimonials but resistance to these compounds has been a persistent problem.
Clara Leandro, Lenea Campino
openaire +3 more sources
Isolation of Chemoresistant Cell Subpopulations
2016Chemoresistance is a major challenge for cancer therapy and drives tumor relapse. The emergence, within the treated tumor mass, of specific cancer cell subpopulations endowed with high tolerance to the microenvironment stress induced by therapy is being growingly recognized as a mechanism of tumor progression. To obtain detailed information with regard
Mario Cioce, Claudia Canino
openaire +3 more sources